Halting the Regulation of AstraZeneca for Awhile

The Philippines is briefly halting regulating AstraZeneca’s COVID-19 antibodies to those under 60 after the European Medicine Agency (EMA) found that blood coagulating joined with low platelet tally is a potential, albeit exceptionally uncommon symptom of the shot.

The EMAhighlighted recently that it tracked down a potential connection between extremely uncommon instances of blood coagulating with low platelet tally and getting the AstraZeneca shot. The EMA shared that a large portion of these cases were accounted for among ladies under 60 years old inside about fourteen days of inoculation.



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
The Asian Affairs

Sharing the latest news from 4 different countries in SouthEast Asia (SEA). Stay updated with us via our social media platforms!